X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (22) 22
female (19) 19
male (19) 19
adult (18) 18
infectious diseases (12) 12
middle aged (12) 12
hiv (9) 9
hiv infections - drug therapy (9) 9
cd4 lymphocyte count (8) 8
index medicus (7) 7
pharmacology & pharmacy (7) 7
retrospective studies (7) 7
risk factors (7) 7
antiretroviral therapy (5) 5
hiv infections - immunology (5) 5
immunology (5) 5
italy (5) 5
italy - epidemiology (5) 5
mortality (5) 5
public, environmental & occupational health (5) 5
virology (5) 5
aged (4) 4
aids (4) 4
anti-hiv agents - therapeutic use (4) 4
cohort studies (4) 4
drug therapy, combination (4) 4
efficacy (4) 4
hiv infections - complications (4) 4
hiv infections - epidemiology (4) 4
hiv infections - virology (4) 4
hiv-1 - genetics (4) 4
infections (4) 4
prevalence (4) 4
sex factors (4) 4
active antiretroviral therapy (3) 3
antiretroviral therapy, highly active (3) 3
cd4 antigen (3) 3
death (3) 3
hepatitis (3) 3
hiv infection (3) 3
hiv-1 - drug effects (3) 3
hiv-infected patients (3) 3
human immunodeficiency virus--hiv (3) 3
incidence (3) 3
infected patients (3) 3
microbiology (3) 3
mutation (3) 3
patients (3) 3
reverse transcriptase inhibitors - therapeutic use (3) 3
risk (3) 3
rna (3) 3
safety (3) 3
acquired immune deficiency syndrome--aids (2) 2
adolescent (2) 2
age factors (2) 2
aids-defining cancers (2) 2
analysis (2) 2
anti-hiv agents - administration & dosage (2) 2
anti-hiv agents - adverse effects (2) 2
antiretroviral drugs (2) 2
antiretroviral therapy, highly active - adverse effects (2) 2
antiretroviral therapy, highly active - methods (2) 2
area under curve (2) 2
blood donation (2) 2
cholesterol (2) 2
cholesterol - blood (2) 2
cohort (2) 2
combination therapy (2) 2
comorbidity (2) 2
diabetes (2) 2
disease (2) 2
disease progression (2) 2
drug resistance, viral (2) 2
efavirenz (2) 2
era (2) 2
evolution (2) 2
follow-up studies (2) 2
gb virus c (2) 2
gender (2) 2
genotype (2) 2
haart (2) 2
hepacivirus - genetics (2) 2
hepatitis c (2) 2
hepatitis c - complications (2) 2
hepatitis c antibodies - blood (2) 2
highly active antiretroviral therapy (2) 2
hiv infections - economics (2) 2
hiv patients (2) 2
hiv seropositivity - immunology (2) 2
hiv-1 (2) 2
hiv-1-infected patients (2) 2
human immunodeficiency virus (2) 2
human-immunodeficiency-virus (2) 2
immunodeficiency (2) 2
immunodeficiency-virus type-1 (2) 2
lamivudine - therapeutic use (2) 2
liver-enzyme elevation (2) 2
longitudinal studies (2) 2
lymphocytes t (2) 2
medicine (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMC Public Health, ISSN 1471-2458, 11/2016, Volume 16, Issue 1, pp. 1 - 10
Journal Article
AIDS Care, ISSN 0954-0121, 12/2016, Volume 28, Issue 12, pp. 1551 - 1558
Journal Article
International Journal of Epidemiology, ISSN 0300-5771, 2017, Volume 46, Issue 2, p. e12
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2015, Volume 10, Issue 5, p. e0124741
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 8/2011, Volume 66, Issue 8, pp. 1886 - 1896
Journal Article
Journal Article
Open Forum Infectious Diseases, ISSN 2328-8957, 10/2019, Volume 6, Issue Supplement_2, pp. S679 - S680
Abstract Background Antimicrobial resistance (AMR) situation in Italian hospitals and regions represents a major public health threat [ECDC, 2017].... 
Journal Article
Journal Article
Drug Safety, ISSN 0114-5916, 2007, Volume 30, Issue 12, pp. 1161 - 1169
Background: Nevirapine-containing regimens have been associated with a risk of significant elevations of liver transaminase levels. Higher risk in... 
Antiretrovirals, adverse reactions | Liver disorders, drug induced | Antiretrovirals, therapeutic use | Nevirapine, adverse reactions | Hepatitis C, general | Nevirapine, therapeutic use | Liver dysfunction, drug induced | EFFICACY | SAFETY | ANTIRETROVIRAL THERAPY | TOXICITY | CD4 CELL COUNT | INDUCED LIVER-INJURY | HIV-INFECTED PATIENTS | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | EFAVIRENZ | DISEASE | PHARMACOLOGY & PHARMACY | TOXICOLOGY | INHIBITORS | HIV-1 | Liver - enzymology | Hepacivirus - immunology | Humans | Male | Nevirapine - therapeutic use | Alanine Transaminase - blood | Nevirapine - adverse effects | Reverse Transcriptase Inhibitors - administration & dosage | Anti-HIV Agents - administration & dosage | Reverse Transcriptase Inhibitors - adverse effects | HIV Infections - immunology | Hepatitis C - immunology | Liver - drug effects | Hepatitis C Antibodies - blood | Adult | Anti-HIV Agents - therapeutic use | Female | Hepatitis C - complications | Retrospective Studies | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination | Chemical and Drug Induced Liver Injury - etiology | Liver Function Tests | Anti-HIV Agents - adverse effects | Risk Factors | CD4 Lymphocyte Count | Aspartate Aminotransferases - blood | HIV Infections - complications | Sex Factors | HIV Infections - drug therapy | Nevirapine - administration & dosage | Cohort Studies
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 07/2005, Volume 56, Issue 1, pp. 190 - 195
Journal Article